![Joshua Britton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joshua Britton
Founder at Debut Biotechnology, Inc.
Joshua Britton active positions
Companies | Position | Start | End |
---|---|---|---|
Debut Biotechnology, Inc.
![]() Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Director/Board Member | 2018-12-31 | - |
Chief Executive Officer | 2019-03-31 | - | |
Founder | 2018-12-31 | - | |
Cantos Ventures, LLC
![]() Cantos Ventures, LLC Investment ManagersFinance Cantos Ventures LLC (Cantos Ventures) is a venture capital firm founded in 2016 by Ian Rountree. The firm is headquartered in San Francisco, California. | Consultant / Advisor | 2020-11-30 | - |
Career history of Joshua Britton
Training of Joshua Britton
The University of Nottingham | Graduate Degree |
Flinders University | Doctorate Degree |
Statistics
International
United States | 3 |
United Kingdom | 2 |
Australia | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Cantos Ventures, LLC
![]() Cantos Ventures, LLC Investment ManagersFinance Cantos Ventures LLC (Cantos Ventures) is a venture capital firm founded in 2016 by Ian Rountree. The firm is headquartered in San Francisco, California. | Finance |
Debut Biotechnology, Inc.
![]() Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Joshua Britton
- Experience